This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shaw, L. N.
Right arrow Articles by Potempa, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shaw, L. N.
Right arrow Articles by Potempa, J.

 Previous Article  |  Next Article 

Journal of Bacteriology, March 2005, p. 1751-1762, Vol. 187, No. 5
0021-9193/05/$08.00+0     doi:10.1128/JB.187.5.1751-1762.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Cytoplasmic Control of Premature Activation of a Secreted Protease Zymogen: Deletion of Staphostatin B (SspC) in Staphylococcus aureus 8325-4 Yields a Profound Pleiotropic Phenotype

Lindsey N. Shaw,1,{dagger} Ewa Golonka,2,{dagger} Grzegorz Szmyd,2 Simon J. Foster,3 James Travis,1 and Jan Potempa1,2*

Department of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia,1 Faculty of Biotechnology, Jagiellonian University, Cracow, Poland,2 Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield, England3

Received 4 October 2004/ Accepted 29 November 2004

The cytoplasmic protein SspC of Staphylococcus aureus, referred to as staphostatin B, is a very specific, tightly binding inhibitor of the secreted protease staphopain B (SspB). SspC is hypothesized to protect intracellular proteins against proteolytic damage by prematurely folded and activated staphopain B (M. Rzychon, A. Sabat, K. Kosowska, J. Potempa, and A. Dubin, Mol. Microbiol. 49:1051-1066, 2003). Here we provide evidence that elimination of intracellular staphopain B activity is indeed the function of SspC. An isogenic sspC mutant of S. aureus 8325-4 exhibits a wide range of striking pleiotropic alterations in phenotype, which distinguish it from the parent. These changes include a defect in growth, a less structured peptidoglycan layer within the cell envelope, severely decreased autolytic activity, resistance to lysis by S. aureus phages, extensively diminished sensitivity to lysis by lysostaphin, the ability to form a biofilm, and a total lack of extracellular proteins secreted into the growth media. The same phenotype was also engineered by introduction of sspB into an 8325-4 sspBC mutant. In contrast, sspC inactivation in the SH1000 strain did not yield any significant changes in the mutant phenotype, apparently due to strongly reduced expression of sspB in the sigma B-positive background. The exact pathway by which these diverse aberrations are exerted in 8325-4 is unknown, but it is apparent that a very small amount of staphopain B (less than 20 ng per 200 µg of cell proteins) is sufficient to bring about these widespread changes. It is proposed that the effects observed are modulated through the proteolytic degradation of several cytoplasmic proteins within cells lacking the inhibitor. Seemingly, some of these proteins may play a role in protein secretion; hence, their proteolytic inactivation by SspB has pleiotropic effects on the SspC-deficient mutant.

* Corresponding author. Mailing address: Department of Biochemistry and Molecular Biology, University of Georgia, Life Sciences Bldg., Athens, GA 30602. Phone: (706) 542-1713. Fax: (706) 542-3719. E-mail: potempa{at}uga.edu.

{dagger} L.N.S. and E.G. contributed equally to this work.

Journal of Bacteriology, March 2005, p. 1751-1762, Vol. 187, No. 5
0021-9193/05/$08.00+0     doi:10.1128/JB.187.5.1751-1762.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Nickerson, N. N., Prasad, L., Jacob, L., Delbaere, L. T., McGavin, M. J. (2007). Activation of the SspA Serine Protease Zymogen of Staphylococcus aureus Proceeds through Unique Variations of a Trypsinogen-like Mechanism and Is Dependent on Both Autocatalytic and Metalloprotease-specific Processing. J. Biol. Chem. 282: 34129-34138 [Abstract] [Full Text]  
  • Shaw, L. N., Jonsson, I.-M., Singh, V. K., Tarkowski, A., Stewart, G. C. (2007). Inactivation of traP Has No Effect on the Agr Quorum-Sensing System or Virulence of Staphylococcus aureus. Infect. Immun. 75: 4519-4527 [Abstract] [Full Text]  
  • Shaw, L. N., Aish, J., Davenport, J. E., Brown, M. C., Lithgow, J. K., Simmonite, K., Crossley, H., Travis, J., Potempa, J., Foster, S. J. (2006). Investigations into {sigma}B-Modulated Regulatory Pathways Governing Extracellular Virulence Determinant Production in Staphylococcus aureus.. J. Bacteriol. 188: 6070-6080 [Abstract] [Full Text]  
  • Wootton, M., Bennett, P. M., MacGowan, A. P., Walsh, T. R. (2005). Reduced expression of the atl autolysin gene and susceptibility to autolysis in clinical heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA) and GISA strains. J Antimicrob Chemother 56: 944-947 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»